FDA Investigator Andrew Le
Andrew Le has inspections in 2 countries as of 21 Sep 2023. Andrew Le has collaborated with a combined 1125 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
9
Last Inspection Date:
21 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
India,
United States of America
Co-Investigator(s):
Alan P Kurtzberg,
Anastasia M Shields,
Angela E Glenn,
Anita Narula, PhD,
Arsen Karapetyan,
Barbara Janine Breithaupt,
Barbara M Frazier,
Binh T Nguyen,
Caryn M Mcnab,
Cheryl A Clausen,
Christopher D Leach,
Claudia Mperez Kasmarski,
Courtney N Long,
Dandan Wang, PhD,
Darren S Brown,
Deborah A Greco,
Debra I Love,
Diane Cvan Leeuwen,
Esther B Gamallo Herrera,
Esther Bgamello Herrera,
Helen Verdel,
Hung H Do, MS,
Jeffrey P Raimondi,
Jennifer C Adams,
Joey V Quitania,
John A Gonzalez,
Jose R Hernandez,
Kham Phommachanh,
Khoa Nathanv Tran,
Kim Lthomas Cruse,
Linda M Cheny,
Lisa Shin,
Makini Cobourne Duval, PhD,
Marijo B Kambere, PhD,
Matthew B Casale,
Melkamu Getie Kebtie, PhD,
Nayan J Patel,
Nicholas A Violand,
Paraluman S Leonin,
Parul M Patel,
Phillip L Toy,
Pratik S Upadhyay, DDC,
Rafeeq A Habeeb,
Robert J Doyle,
S Lori Brown, PhD MPH,
Sangeeta M Khurana, PhD,
Santiago Gallardo Johnson,
Sharon K Thoma, PharmD,
Stacey S Degarmo,
Taichun Qin, PhD,
Tamil Arasu, PhD,
Tenzin Jangchup,
Tracey T Duong,
Tracy K Li,
Truong Xuan Nguyen (Andy),
Virgilio F Pacio, CSO,
Zachary A Bogorad,
Zachary L Miller,
Zachary L Stamm
Andrew Le's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2022 | FDA 483 | KARI GRAN - Form 483, 2022-07-08 |
December, 2022 | FDA 483 | Mr. Lulu - Form 483, 2022-12-09 |
August, 2022 | FDA 483 | Clean Cosmetics, LLC - Form 483, 2022-08-19 |
June, 2022 | EIR | PETNET SOLUTIONS, INC. - EIR, 2022-06-15 |
November, 2022 | FDA 483 | Yusef Manufacturing Laboratories, LLC DBA YMlabs, LLC - Form 483, 2022-11-04 |
February, 2023 | FDA 483 | ACTA LABORATORIES - Form 483, 2023-02-13 |
July, 2023 | FDA 483 | Sun Pharmaceutical Medicare Limited - Form 483, 2023-07-13 |
September, 2023 | FDA 483 | Orange Lab - Form 483, 2023-10-25 |
November, 2023 | FDA 483 | Wedgewood Connect, LLC - Form 483, 2023-11-17 |
February, 2024 | FDA 483 | PUREMEDY - Form 483, 2024-02-12 |
July, 2023 | FDA 483 | Aurobindo Pharma Limited - Form 483, 2023-07-21 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more